RESEARCH

Mafalda is fascinated by how tiny things such as viruses, bacteria or mutations in our DNA cause illnesses.

After a brief period working in biotechnology, she started by studying the effects of a potential anti-cancer drug in the mitochondrial metabolism of hepatocarcinoma (liver cancer) cells. Currently, Mafalda's research is focused on how a family of viruses, called Flaviviruses, are able to escape the cell's innate immune response. 

ACADEMIC JOURNEY

PHD STUDENT IN IMMUNOLOGY

University of Surrey
Guildford, United Kingdom
2016 - now

Department of Biochemical Sciences, Immunology Section

Supervised by Dr Peter Mayerhofer and Dr Rachel Simmonds.

RESEARCH INTERNSHIP

Academic Medical Centre, University of Amsterdam
Amsterdam, Netherlands
September 2014 - December 2014
Laboratory Genetic Metabolic Diseases

Supervised by Dr Ronald JA Wanders.

MASTERS DEGREE IN BIOPHARMACEUTICAL SCIENCES

Faculty of Pharmacy, University of Lisbon

Lisbon, Portugal

2013-2015

Drug discovery - Metabolism and Genetics

Supervised by Dr Margarida FB Silva (FFUL, UL) and Dr Ronald JA Wanders (AMC, UvA). Thesis title: "The role of a KDAC inhibitor in nitrogen metabolism: the therapeutic challenges for liver disease and hepatocellular carcinoma."

SCIENTIFIC RESEARCH TRAINING COURSE

Institute of Chemistry and Biologic Technology (ITQB)

Oeiras, Portugal

September 2012 - March 2013

Plant Cell Biology Laboratory

Supervised by Dr Rita Abranches. Project title: "Establishment of cell suspension cultures of Medicago truncatula expressing human recombinant L-PGDS enzyme by transformation mediated by Agrobacterium tumefaciens."

BACHELOR IN CELLULAR AND MOLECULAR BIOLOGY

Faculty of Sciences and Technology (FCT), New University of Lisbon (UNL)
Almada, Portugal
2009-2013


ACADEMIC WRITING

Below is the collection of published scientific papers to which I am an author.

Screen Shot 2018-07-10 at 23.34.49.png

ADVANCES IN METHODS FOR CHARACTERIZATION OF HEPATIC UREA CYCLE ENZYMATIC ACTIVITY IN HEPARG CELLS USING UPLC-MS/MS.

DRUG-INDUCED EFFECTS ON UREA CYCLE ENZYMES ASSOCIATE WITH ALTERED AMMONIA METABOLISM, NAD+ BIOSYNTHESIS AND MITOCHONDRIAL PROTEIN ACETYLOME.